RS49890B - Preparat u formi praška koji sadrži medicinsko sredstvo velike molekulske težine za primenu preko sluzokože - Google Patents

Preparat u formi praška koji sadrži medicinsko sredstvo velike molekulske težine za primenu preko sluzokože

Info

Publication number
RS49890B
RS49890B YUP-11/01A YU1101A RS49890B RS 49890 B RS49890 B RS 49890B YU 1101 A YU1101 A YU 1101A RS 49890 B RS49890 B RS 49890B
Authority
RS
Serbia
Prior art keywords
mucosa
molecular weight
high molecular
administration
powder form
Prior art date
Application number
YUP-11/01A
Other languages
English (en)
Inventor
Hideaki NOMURA
Yosuke UEKI
Original Assignee
Kirin-Amgen Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26422571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49890(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kirin-Amgen Inc., filed Critical Kirin-Amgen Inc.,
Publication of YU1101A publication Critical patent/YU1101A/sh
Publication of RS49890B publication Critical patent/RS49890B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1. Preparat u formi praška za primenu preko sluzokože, koji sadrži lek velike molekulske težine, izabran iz grupe koja se sastoji od bioaktivnih peptida i proteina, antitela, vakcina i antigena, kao i od aminoalkilmetakrilatnog kopolimera ili polivinil acetal dietilaminoacetata.
YUP-11/01A 1998-07-08 1999-07-01 Preparat u formi praška koji sadrži medicinsko sredstvo velike molekulske težine za primenu preko sluzokože RS49890B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19272298 1998-07-08
JP8154999 1999-03-25

Publications (2)

Publication Number Publication Date
YU1101A YU1101A (sh) 2003-08-29
RS49890B true RS49890B (sr) 2008-08-07

Family

ID=26422571

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-11/01A RS49890B (sr) 1998-07-08 1999-07-01 Preparat u formi praška koji sadrži medicinsko sredstvo velike molekulske težine za primenu preko sluzokože

Country Status (27)

Country Link
US (2) US20050271728A1 (sr)
EP (2) EP1637154A3 (sr)
JP (1) JP3422775B2 (sr)
KR (1) KR100606857B1 (sr)
CN (1) CN1180839C (sr)
AT (1) ATE320816T1 (sr)
AU (1) AU764331B2 (sr)
BG (1) BG65040B1 (sr)
BR (1) BR9911890A (sr)
CA (1) CA2332559C (sr)
CZ (1) CZ300931B6 (sr)
DE (1) DE69930509T2 (sr)
DK (1) DK1093818T3 (sr)
EA (1) EA003672B1 (sr)
ES (1) ES2260916T3 (sr)
HK (1) HK1039283B (sr)
HU (1) HUP0103396A3 (sr)
IL (2) IL140669A0 (sr)
MX (1) MXPA01000032A (sr)
NO (1) NO20010042L (sr)
NZ (1) NZ509710A (sr)
PL (1) PL193805B1 (sr)
PT (1) PT1093818E (sr)
RS (1) RS49890B (sr)
SK (1) SK262001A3 (sr)
TW (1) TWI225411B (sr)
WO (1) WO2000002574A1 (sr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282219B2 (en) 2000-03-31 2007-10-16 Kirin Beer Kabushiki Kaisha Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
AU7105501A (en) * 2000-07-17 2002-01-30 Yamanouchi Pharma Co Ltd Pharmaceutical composition improved in peroral absorbability
CA2472449C (en) * 2002-01-16 2010-03-09 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceutical composition for oral use with improved absorption
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
JP5283334B2 (ja) * 2003-01-24 2013-09-04 マグル ホールディング エービー 経粘膜伝達用組成物材料
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
ES2399053T3 (es) 2004-10-11 2013-03-25 Nasaleze Patents Limited Composiciones para administración intranasal
CA2583794C (en) * 2004-10-11 2015-05-26 Nasaleze Ppm Limited Compositions for intranasal administration
JP5103748B2 (ja) * 2005-02-16 2012-12-19 東レ株式会社 医薬組成物
CU23317A1 (es) * 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
US8268307B2 (en) * 2007-03-19 2012-09-18 University Of Florida Research Foundation, Inc. Enhancing efficacy of vaccines administered via the respiratory tract
JP5171102B2 (ja) * 2007-05-02 2013-03-27 東亜薬品株式会社 経鼻吸収用睡眠導入剤
JP2012504150A (ja) * 2008-09-29 2012-02-16 ザ・コーポレーション・オブ・メイサー・ユニバーシティー 生体活性材料をカプセル化したナノスフェアおよびナノスフェアの製剤化のための方法
US11524058B2 (en) 2008-09-29 2022-12-13 The Corporation Of Mercer University Oral dissolving films containing microencapsulated vaccines and methods of making same
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
US10004790B2 (en) 2008-09-29 2018-06-26 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration
US9060938B2 (en) * 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
GB201109311D0 (en) * 2011-06-03 2011-07-20 Avimir Ip Ltd Method and computer program for providing authentication to control access to a computer system
US20150079130A1 (en) * 2012-04-04 2015-03-19 Vaxform, LLC Adjuvant system for oral vaccine administration
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
US11628208B2 (en) 2015-10-05 2023-04-18 The Corporation Of Mercer University System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
WO2017062463A1 (en) 2015-10-05 2017-04-13 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
EP3459529A1 (en) * 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
WO2019245373A1 (en) * 2018-06-22 2019-12-26 Bioralix B.V. Formulations of biological polymers for oral administration
HUE060573T2 (hu) 2020-05-18 2023-03-28 Orexo Ab Új gyógyászati készítmény gyógyszerbejuttatáshoz
TW202333658A (zh) 2021-11-25 2023-09-01 瑞典商奥瑞克索股份公司 包含腎上腺素之新穎醫藥組合物
EP4226912A1 (en) * 2022-02-09 2023-08-16 Catalya A polymer to increase the bioavailability of a pharmaceutical compound

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US807552A (en) * 1904-07-30 1905-12-19 John Guiry Dumping-scow.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JP2577743B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4721020A (en) * 1986-10-27 1988-01-26 Stumpf Gary B Ski sharpening guide and method of employing same
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
JP2841714B2 (ja) * 1990-05-22 1998-12-24 大正製薬株式会社 持効性点鼻剤
JP3283288B2 (ja) * 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
JPH07118170A (ja) * 1993-10-19 1995-05-09 Dot:Kk 経鼻吸収薬物用キャリヤ、生理活性ペプチド組成物およびその製造法
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5783178A (en) * 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
JPH08198772A (ja) * 1994-11-25 1996-08-06 Kirin Brewery Co Ltd 顆粒球コロニー刺激因子含有粉末経鼻投与製剤
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
JP3197221B2 (ja) * 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
JP3197222B2 (ja) * 1996-02-28 2001-08-13 帝人株式会社 粉末状経鼻投与組成物
JP3770666B2 (ja) * 1996-09-20 2006-04-26 株式会社ティ・ティ・エス技術研究所 経粘膜吸収製剤用組成物
EP0896823B1 (en) * 1997-07-15 2002-09-25 Development Center For Biotechnology Improved stabilization of Misoprostol
JP2001518490A (ja) * 1997-10-03 2001-10-16 エラン コーポレーシヨン ピーエルシー 味遮蔽された製剤
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US8075520B2 (en) * 2006-04-06 2011-12-13 Reznik Alan M Arthroscopic fluid control device and method for controlling fluid flow in arthroscopic procedures

Also Published As

Publication number Publication date
NZ509710A (en) 2003-10-31
EA003672B1 (ru) 2003-08-28
EP1637154A2 (en) 2006-03-22
CZ300931B6 (cs) 2009-09-16
KR20010053302A (ko) 2001-06-25
HUP0103396A2 (hu) 2002-02-28
AU4395899A (en) 2000-02-01
PL345456A1 (en) 2001-12-17
MXPA01000032A (es) 2002-10-17
EP1093818B1 (en) 2006-03-22
BG105169A (en) 2001-12-29
HK1039283B (zh) 2005-04-29
CZ20016A3 (en) 2001-05-16
ATE320816T1 (de) 2006-04-15
IL140669A (en) 2007-06-03
CN1315864A (zh) 2001-10-03
US20050271728A1 (en) 2005-12-08
CN1180839C (zh) 2004-12-22
HK1039283A1 (en) 2002-04-19
JP3422775B2 (ja) 2003-06-30
EP1093818B9 (en) 2007-10-17
HUP0103396A3 (en) 2002-05-28
BG65040B1 (bg) 2007-01-31
EP1637154A3 (en) 2007-08-15
EA200100118A1 (ru) 2001-08-27
EP1093818A1 (en) 2001-04-25
NO20010042L (no) 2001-03-05
YU1101A (sh) 2003-08-29
DK1093818T3 (da) 2006-07-17
KR100606857B1 (ko) 2006-08-01
AU764331B2 (en) 2003-08-14
CA2332559C (en) 2008-01-15
SK262001A3 (en) 2001-09-11
EP1093818A4 (en) 2004-03-31
PL193805B1 (pl) 2007-03-30
DE69930509D1 (de) 2006-05-11
DE69930509T2 (de) 2006-11-30
TWI225411B (en) 2004-12-21
WO2000002574A1 (fr) 2000-01-20
BR9911890A (pt) 2001-03-27
CA2332559A1 (en) 2000-01-20
US20090028814A1 (en) 2009-01-29
PT1093818E (pt) 2006-07-31
NO20010042D0 (no) 2001-01-04
IL140669A0 (en) 2002-02-10
ES2260916T3 (es) 2006-11-01

Similar Documents

Publication Publication Date Title
RS49890B (sr) Preparat u formi praška koji sadrži medicinsko sredstvo velike molekulske težine za primenu preko sluzokože
DE60125797D1 (de) Impfstoffzusammesetzung
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
EE05309B1 (et) β-Amloidpeptiidi „ratundvad humaniseeritud antikehad, meetod nende valmistamiseks, nende kasutamine ja farmatseutiline kompositsioon
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
DE69231663D1 (de) Konjugate bestehend aus polysaccharid und protein
FR2809731B1 (fr) Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
BR0210772A (pt) Usos de um anticorpo anti-hla, e de uma composição de soro de cabra
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
SE0001916D0 (sv) Novel formulation
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
FR2805259B1 (fr) Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2675799B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
DE60121925D1 (de) Arzneimittel zur verabreichung an schleimhäute
FR2842527B1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
HRP20070081T5 (en) Nasal pharmaceutical composition of piribedil
DE69706657D1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung